Delivery Order SPE2DB25D2204-SPE2DB25FTGXM
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $8,093.94 to AmerisourceBergen Drug Corp for the supply of Drospirenone 4mg 28-count units under contract 4568868132. This firm fixed price delivery order, awarded on July 23, 2025, represents a non-competitive set-aside contract with an ultimate completion date of August 19, 2025. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $3,756.98 order is for the delivery of 4563715937 - DROSPIRENONE-EE 3-0.02 MG TAB 28S, a pharmaceutical product, to be delivered by February 21, 2024. No set-aside designation was used for this award. AmerisourceBergen Drug Corp, through its Corporate Office division in...
- The Defense Logistics Agency Troop Support Medical awarded a $3,448.82 firm fixed price delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division for the delivery of 4561522410 Drospirenone-EE 3-0.02 mg tab 28s. The place of performance is Conshohocken, Pennsylvania. The contract period of performance is July 17, 2023 through July 18, 2023. As the prime contractor, Amerisourcebergen Drug Corp will deliver the requested pharmaceutical product to support the Defense...
- This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of drospirenone-ee 3-0.02 mg tablets. The contract is a firm fixed-price delivery order with a ceiling value of $1,619.08 and a performance period through July 9, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $3,237.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Norgestimate-EE 0.25-0.035 mg 28-tablet pack pharmaceutical supplies. The contract was awarded on August 8, 2025, with an ultimate completion date of August 11, 2025, and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a non-competitive award issued under a larger indefinite delivery contract vehicle. This...
- This is a $1,034.44 Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of DROSPIRENONE-EE 3-0.02 MG TAB 28S medication, with a performance period ending on May 27, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX. This IDC provides a comprehensive...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $1,766.29 for Levonorgestrel 1.5mg tablets from the Medical Supply Chain, a division of the Defense Logistics Agency. The award was issued on August 1, 2025, with an ultimate completion date of August 4, 2025, under a firm fixed-price contract type with no set-aside designation. This delivery order is a child contract under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $136,000 to Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation. The delivery order is for 4561435724 units of low-dose oral contraceptive tablets to be provided over a three-day period from July 7-10, 2023. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania. No subcontractors or set-aside designations were identified. The Defense...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,816.41 to AmerisourceBergen Drug Corp for the supply of Loestrin 21 1.5-30 tablets (21-count package). The contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency awarded a $1,141.53 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Angeliq 0.25 mg-0.5 mg tablets (28-count units). This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, represents a non-set-aside, competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DB25D2204Indefinite Delivery Contract
- SPE2DB25D2204-SPE2DB25FTGXMDelivery Order
The Defense Logistics Agency awarded a $2,816.89 delivery order to AmerisourceBergen Drug Corp for Drospirenone-EE 3-0.02 mg tablets (28-count packaging) on August 21, 2025, with completion scheduled for August 22, 2025. This contract represents a firm fixed-price, competitively awarded delivery order with no set-aside designation. The award was fulfilled by AmerisourceBergen Drug Corp's Corporate Office division, headquartered in Conshohocken, Pennsylvania, which serves as a major pharmaceutical distributor for federal medical procurement needs. This delivery order falls under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The arrangement reflects DLA's strategy of leveraging multiple vendor relationships to ensure reliable pharmaceutical supply chains across the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 8/21/25 |